bongoboy

Tiny Accentia Biopharmaceuticals May Be On Its Way To Big Things

It has been a slow Phase three. But as you know this is not uncommon. I found this off the internet. Yes it is fro m january 2007. But I like who it came from. www.thomsonpharma.com/... They talk about the opportunity. And by the way I think Revimmune and Biovaxid really bring the risk down. Remember it only has a 56 million mkt cap. Look at all the one drug companies who have gotton "no's" fro the fda and somehow maintain 200 to 300 million mkt caps. I have to believe at these prices risk/reward is in my favor. Imagine if they did get their products approved? $30 or $40 Dollars? Who knows, but I like what i see!

Tiny Accentia Biopharmaceuticals May Be On Its Way To Big Things

I see that Accentia Bioparmaceuticals is also owned by PPDI tot he tune of 4,300,000 shares or over 10%. I also notice that Alan Brochstein above states that one can get "sinunase" already. That's true to an extent. Because The drug in Sinunase is already approved doctors are allowed to wrtie off label prescriptions. The fact that it is being prescribed so much by doctors give me a feeling that it just might be doing something good for paitents. The FDA from what I know is not comfortable with all that off label prescriptions w/o their approval. With a little bit of good results perhaps they will get the ok. Also Alan Brochstein just wrote an article about PPDI recently that wall street does not get PPDI and to buy it. You can find it here biotech.seekingalpha.c... . Yet PPDI presents all over the world and list only 4 partner drug compounds they believe could add significant value to shareholders. One of those drugs is SINUNASE. Thomas Weisel belives an approval of Sinunase could add a billion in mkt cap to PPDI. Well they only get 7% royalty on future revenue. Not including the other opportunities i think it is ignorant to say so bluntly that they will be gone so soon. Here is the latest link to PPDI conference. www.ppdi.com/corporate... page 34